These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
57 related articles for article (PubMed ID: 1825572)
1. Ca2+ transients evoked by prostanoids in Swiss 3T3 cells suggest an FP-receptor mediated response. Woodward DF; Fairbairn CE; Goodrum DD; Krauss AH; Ralston TL; Williams LS Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():367-70. PubMed ID: 1825572 [No Abstract] [Full Text] [Related]
2. Characterization of contraction-mediating prostanoid receptors in human hand veins: effects of the thromboxane receptor antagonists BM13,505 and AH23848. Arner M; Högestätt ED; Uski TK Acta Physiol Scand; 1991 Jan; 141(1):79-86. PubMed ID: 2053448 [TBL] [Abstract][Full Text] [Related]
3. Excitatory action of prostanoids on the ferret isolated vagus nerve preparation. Kan KK; Jones RL; Ngan MP; Rudd JA Eur J Pharmacol; 2004 Apr; 491(1):37-41. PubMed ID: 15102531 [TBL] [Abstract][Full Text] [Related]
4. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets. Yin K; Halushka PV; Yan YT; Wong PY J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171 [TBL] [Abstract][Full Text] [Related]
5. Identification of a single (FP) receptor associated with prostanoid-induced Ca2+ signals in Swiss 3T3 cells. Woodward DF; Lawrence RA Biochem Pharmacol; 1994 Apr; 47(9):1567-74. PubMed ID: 8185669 [TBL] [Abstract][Full Text] [Related]
6. Molecular and functional evidence for the distinct nature of F2-isoprostane receptors from those of thromboxane A2. Yura T; Fukunaga M; Grygorczyk R; Makita N; Takahashi K; Badr KF Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():237-9. PubMed ID: 7732843 [No Abstract] [Full Text] [Related]
7. Real-time intracellular Ca2+ mobilization by travoprost acid, bimatoprost, unoprostone, and other analogs via endogenous mouse, rat, and cloned human FP prostaglandin receptors. Kelly CR; Williams GW; Sharif NA J Pharmacol Exp Ther; 2003 Jan; 304(1):238-45. PubMed ID: 12490597 [TBL] [Abstract][Full Text] [Related]
9. The strong contractile effect of the thromboxane receptor agonist U-46619 in isolated human pulmonary arteries and its competitive antagonism by BM-13.505. Sjöberg T; Steen S Acta Physiol Scand; 1989 Jun; 136(2):161-5. PubMed ID: 2528885 [TBL] [Abstract][Full Text] [Related]
10. Effects of putative thromboxane receptor agonists and antagonists on rat small intestinal ion transport. Smith PL; McCafferty GP; Fondacaro JD; Wasserman MA; Elton E; Ryan FM J Pharmacol Exp Ther; 1988 Oct; 247(1):143-9. PubMed ID: 2971796 [TBL] [Abstract][Full Text] [Related]
11. Vascular activities of prostaglandins and selective prostanoid receptor agonists in human retinal microvessels. Spada CS; Nieves AL; Woodward DF Exp Eye Res; 2002 Aug; 75(2):155-63. PubMed ID: 12137761 [TBL] [Abstract][Full Text] [Related]
12. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets. Greenberg SS; Johns A; Kleha J; Xie J; Wang Y; Bianchi J; Conley K J Pharmacol Exp Ther; 1994 Mar; 268(3):1352-61. PubMed ID: 8138950 [TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of the selective thromboxane receptor antagonist BM 13.177 on platelet aggregation, vasoconstriction and sudden death. Patscheke H; Stegmeier K; Müller-Beckmann B; Sponer G; Staiger C; Neugebauer G Biomed Biochim Acta; 1984; 43(8-9):S312-8. PubMed ID: 6097235 [TBL] [Abstract][Full Text] [Related]
15. Reduction of myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion by the thromboxane receptor antagonist BM 13.505. Griswold DE; Egan JW; Earl CQ; Hillegass LM; Marshall PJ; Smith EF Prog Clin Biol Res; 1989; 301():161-5. PubMed ID: 2529547 [No Abstract] [Full Text] [Related]
16. Mechanism of thromboxane receptor activation of phospholipase A2 in endothelial cells. Hunt JA; Keen M Biochem Soc Trans; 1991 Apr; 19(2):99S. PubMed ID: 1832404 [No Abstract] [Full Text] [Related]
17. The dependence of cardiac eicosanoid effects on changes of calcium concentration. Mentz P; Pawelski KE Biomed Biochim Acta; 1984; 43(8-9):S167-70. PubMed ID: 6393963 [TBL] [Abstract][Full Text] [Related]
18. Influence of SK&F 95587 and BN 50730 on bronchoconstrictor responses in the cat. Dyson MC; Bellan JA; Minkes RK; Beckerman RC; Wegmann MJ; Braquet P; McNamara DB; Kadowitz PJ J Pharmacol Exp Ther; 1990 Dec; 255(3):1320-7. PubMed ID: 2175802 [TBL] [Abstract][Full Text] [Related]
19. Prostanoid EP(1)- and TP-receptors involved in the contraction of human pulmonary veins. Walch L; de Montpreville V; Brink C; Norel X Br J Pharmacol; 2001 Dec; 134(8):1671-8. PubMed ID: 11739243 [TBL] [Abstract][Full Text] [Related]
20. Replacement of the carboxylic acid group of prostaglandin f(2alpha) with a hydroxyl or methoxy substituent provides biologically unique compounds. Woodward DF; Krauss AH; Chen J; Gil DW; Kedzie KM; Protzman CE; Shi L; Chen R; Krauss HA; Bogardus A; Dinh HT; Wheeler LA; Andrews SW; Burk RM; Gac T; Roof MB; Garst ME; Kaplan LJ; Sachs G; Pierce KL; Regan JW; Ross RA; Chan MF Br J Pharmacol; 2000 Aug; 130(8):1933-43. PubMed ID: 10952685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]